Author:
Frogne Thomas,Benjaminsen Rikke V.,Sonne-Hansen Katrine,Sorensen Boe S.,Nexo Ebba,Laenkholm Anne-Vibeke,Rasmussen Louise M.,Riese David J.,de Cremoux Patricia,Stenvang Jan,Lykkesfeldt Anne E.
Publisher
Springer Science and Business Media LLC
Reference52 articles.
1. Osborne CK (1999) Tamoxifen in the treatment of breast cancer. N Engl J Med 339:1609–1618
2. Brünner N, Frandsen TL, Holst-Hansen C et al (1993) MCF7/LCC2 A 4-hydroxytamoxifen resistant human breast cancer variant that retains sensitivity to the steroidal antiestrogen ICI 182,780. Cancer Res 53:3229–3232
3. Lykkesfeldt AE, Madsen MW, Briand P (1994) Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1. Cancer Res 54:1587–1595
4. Howell A, DeFriend D, Robertson J et al (1995) Response to a specific antioestrogen (ICI 182780) in tamoxifen-resistant breast cancer. Lancet 345:29–30
5. Howell A (2006) Pure oestrogen antagonists for the treatment of advanced breast cancer. Endocr Relat Cancer 13:689–706
Cited by
132 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献